Skip to main content

Clearwater Capital Advisors, LLC

SEC CIK
0001690531
Latest filing
Aug 6, 2026

IBRX holding history

ImmunityBio, Inc. in every 13F filed by Clearwater Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IBRX overviewAll 13F holders of IBRXFull Q2 2026 holdings

Shares (Q2 2026)
717,524
Value
$6.28M
% of portfolio
0.5%
Quarters held
22
Since Q1 2021
Holdings of IBRX by Clearwater Capital Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026717,524$6.28M0.5%00.0%UnchangedHolders
Q1 2026717,524$5.50M0.4%−127,560−15.1%ReducedHolders
Q4 2025845,084$1.67M0.1%−1,335−0.2%ReducedHolders
Q3 2025846,419$2.08M0.2%00.0%UnchangedHolders
Q2 2025846,419$2.23M0.2%00.0%UnchangedHolders
Q1 2025846,419$2.55M0.2%00.0%UnchangedHolders
Q4 2024846,419$2.17M0.2%+363,870+75.4%AddedHolders
Q3 2024482,549$1.80M0.2%00.0%UnchangedHolders
Q2 2024482,549$3.05M0.3%+39,250+8.9%AddedHolders
Q1 2024443,299$2.38M0.3%00.0%UnchangedHolders
Q4 2023443,299$2.23M0.2%+48,700+12.3%AddedHolders
Q3 2023394,599$666.9K0.1%00.0%UnchangedHolders
Q2 2023394,599$1.10M0.1%+77,448+24.4%AddedHolders
Q1 2023317,151$577.2K0.1%+131,240+70.6%AddedHolders
Q4 2022185,911$942.6K0.1%00.0%UnchangedHolders
Q3 2022185,911$924.0K0.1%+600+0.3%AddedHolders
Q2 2022185,311$689.0K0.1%+37,420+25.3%AddedHolders
Q1 2022147,891$830.0K0.1%+7,340+5.2%AddedHolders
Q4 2021140,551$855.0K0.1%−7,340−5.0%ReducedHolders
Q3 2021147,891$1.44M0.2%+75,865+105.3%AddedHolders
Q2 202172,026$1.03M0.1%00.0%UnchangedHolders
Q1 202172,026$1.71M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.